NCT03545373View on ClinicalTrials.gov

Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,583

Participants

Timeline

Start Date

February 25, 2019

Primary Completion Date

March 14, 2020

Study Completion Date

April 14, 2020

Conditions
TuberculosisRespiratory Tract InfectionsPneumonia
Interventions
DRUG

Azithromycin

Azithromycin tablet taken orally

DRUG

Amoxicillin

Amoxicillin tablets taken orally

Trial Locations (1)

00265

University of Malawi College of Medicine, Blantyre

All Listed Sponsors
collaborator

Kamuzu University of Health Sciences

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT03545373 - Accuracy and Consequences of Using Trial-of-antibiotics for TB Diagnosis (ACT-TB Study) | Biotech Hunter | Biotech Hunter